Pandemic insurance

Category: Emerging risks · Reviewed by Simon Temme, Account Executive · Last reviewed 2026-06-10

Pandemic insurance is a heterogeneous class of cover, parametric trigger or pooled-market scheme intended to indemnify policyholders for business interruption, event cancellation, mortality or healthcare losses arising from declared epidemic or pandemic outbreaks of communicable disease.

The COVID-19 pandemic exposed the limits of conventional business interruption (BI) wordings and prompted the United Kingdom Supreme Court ruling in Financial Conduct Authority v Arch Insurance (UK) Ltd & Others [2021] UKSC 1, which found in favour of policyholders on the construction of certain disease and prevention-of-access clauses. The decision, alongside HM Treasury and Association of British Insurers (ABI) discussions on a “Pandemic Re” scheme, has framed the subsequent market for dedicated pandemic insurance products in the UK.

Definition

Pandemic insurance comprises insurance contracts and risk-transfer arrangements that respond specifically to losses caused by epidemic or pandemic infectious disease, including:

• Business interruption following enforced closures, supply chain disruption or denial of access.
• Event cancellation and abandonment triggered by official advice or prohibition of mass gatherings.
• Healthcare and mortality stress affecting life and health insurers and pension funds.
• Parametric solutions triggered by World Health Organization (WHO) declarations, official case counts or named-disease indices.

It is distinct from generic business interruption cover, which historically excluded or was silent on communicable disease, and from political-violence or property classes.

Legal and regulatory basis

The UK statutory and regulatory framework relevant to pandemic insurance includes:

• Public Health (Control of Disease) Act 1984 — the principal Act under which the Secretary of State may make regulations to prevent the spread of infection, including premises closures.
• Coronavirus Act 2020 — the emergency legislation enacted on 25 March 2020 conferring temporary powers in respect of COVID-19; provided context for “action of a competent authority” and “prevention of access” trigger language.
• Financial Services and Markets Act 2000 — the regulatory perimeter for insurers and intermediaries (see FSMA 2000).
• FCA Handbook ICOBS — product information and customer’s best interests obligations bearing on disclosure of pandemic exclusions (see ICOBS).
• PRA Rulebook and SS5/17 — prudential and reserving expectations applicable to general insurers underwriting pandemic exposure.

The Supreme Court’s judgment in FCA v Arch Insurance (UK) Ltd & Others [2021] UKSC 1 established that “disease” clauses referring to occurrences “within” a defined radius could be triggered by a single occurrence of COVID-19 within that radius even where the wider pandemic was the dominant proximate cause, and that “prevention of access” and “hybrid” clauses could respond to enforced closures.

How it works in practice

Pandemic insurance is generally placed through one of four mechanisms:

1. Indemnity-based property/BI extensions — narrow named-disease extensions remain available in some markets but with sub-limits, exclusions for COVID-19 strains and capped indemnity periods.
2. Parametric pandemic cover — triggers tied to WHO PHEIC declarations, reported case thresholds in a defined territory or named-disease indices (for example, Marsh’s PathogenRX, written into Munich Re Epidemic Risk Solutions).
3. Event cancellation extensions — specific communicable-disease extensions offered in the Lloyd’s of London market with sub-limited capacity.
4. Public-private pools — analogous to Pool Re and Flood Re; successive proposals for a “Pandemic Re” backstop have been considered by HM Treasury, ABI and IUA but no scheme has been enacted at the time of writing.

Capacity remains limited and pricing materially elevated relative to the pre-2020 baseline.

Common variations and subsequent developments

• Communicable disease exclusions (LMA 5391, 5392, 5393, 5394) — Lloyd’s Market Association model clauses promulgated in 2020 are now in widespread use across property, BI and event classes.
• Named-peril carve-backs — limited carve-back wordings naming specific pathogens (for example Ebola, Marburg) with strict sub-limits.
• Parametric and ILS structures — interest in insurance-linked securities referencing pandemic triggers; the World Bank’s Pandemic Emergency Financing Facility (closed 2020) provided a template.
• Pandemic Re feasibility — ABI and HM Treasury joint workstreams (2020 to 2023) on a UK government-backed reinsurance pool.

Example

A UK conference organiser purchases an event cancellation policy in 2025 with a communicable-disease extension on a Lloyd’s slip. The extension carries a sub-limit of GBP 2 million, a 28-day waiting period and is triggered by a WHO Public Health Emergency of International Concern declaration plus government prohibition of mass gatherings within the venue’s local authority area. When a 2026 outbreak prompts the WHO declaration and the relevant Secretary of State exercises powers under the Public Health (Control of Disease) Act 1984 to ban gatherings, the policy responds up to the sub-limit. Underlying property damage BI cover does not respond, because LMA 5391 excludes communicable disease.

See also

• Business interruption
• FCA v Arch
• Parametric insurance
• Pool Re
• Flood Re
• Reinsurance
• Insurance-linked securities
• ICOBS
• Lloyd’s of London

References

• Financial Conduct Authority v Arch Insurance (UK) Ltd & Others [2021] UKSC 1.
• Public Health (Control of Disease) Act 1984, legislation.gov.uk.
• Coronavirus Act 2020, legislation.gov.uk.
• HM Treasury and Association of British Insurers, joint statements on pandemic risk-sharing (2020–2023).
• Lloyd’s Market Association, LMA 5391–5394 communicable disease exclusion clauses (2020).
• Geneva Association, “An Investigation into the Insurability of Pandemic Risk” (2021).
• Marsh, “PathogenRX” technical note.
• Munich Re, “Epidemic Risk Solutions” briefings.
• World Health Organization, International Health Regulations (2005).

This entry is part of the Apex Insurance Wiki. Last reviewed by Apex Insurance Brokers on 2026-06-10. Next review: 2026-12-10.

Apex Insurance Brokers Limited. Authorised and regulated by the Financial Conduct Authority, FRN 724952. Registered in England and Wales, Companies House 07014570. This entry provides general information about UK insurance concepts and is not regulated advice. Consult your insurance broker on your specific position.